ERBB2 and breast carcinoma: They also display loss of estrogen receptor (ER) and progesterone receptor expression (PR), overexpression of ErbB2 and cyclin D1 as the disease progresses (Fig. 2), mimicking human breast cancers with poor prognosis [3, 7].